Alcohol AddictionTAC-ADDICTNCT07369245
Techniques for Activating Consciousness (TAC) for Outpatients With Moderate to Severe Alcohol Addiction
A study testing TAC intervention in people with Alcohol Addiction, run by Versailles Hospital at 2 sites in France.
Trial summary
Many patients are considering the use of so-called "hypnosis" treatments in the field of addictions. However, these techniques lack sufficient levels of evidence with regard to the standards required by Evidence-Based Medicine. Read more about this study
- Who is it for?
- Ages 18 years and older
- Conditions the study is for
- Alcohol Addiction
- What is being tested?
- TAC intervention
- Type of treatment
- Lifestyle or therapy programme
- Could I receive a placebo?
- No, everyone receives an active treatment
- How many people
- 98 participants
- Where
- 2 sitesFrance
- Study dates
- 15 Apr 2026to 15 Jan 2028
- Phase
- Interventional
- Are there results?
- Not yet: the study is under way
Key requirements
Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.
- Ages 18 years and older
- All sexes
- No healthy volunteers
- Adult, Older adult
Who may be able to join
- Adult patients consulting for an alcohol-related addiction problem at the CSAPA of Versailles (sites in Versailles, Trappes, Rambouillet) or at the Centre Hospitalier des 4 Villes (day hospital or CSAPA in Sèvres)
- Patients must meet at least 4 of the 11 DSM-5 criteria (Annex 2), corresponding to moderate to severe addiction
- Patients must be affiliated with the French social security system
Who cannot join
- Refusal to participate
- Decompensated psychiatric pathology contraindicating therapy:
- Presence at inclusion of delusional, dissociative, and/or persecutory symptoms
- Presence at inclusion of hypomanic or manic decompensation
- Severe cognitive impairment, evidenced by inability to perform the clock-drawing test (draw the clock face, place the numbers, and set the hands to 11:10)
- Adults legally protected under French law (deprivation of liberty, legal safeguard, guardianship, curatorship)
- Inability to understand French
Trial locations and contacts
2 sites in 1 country. Contact the study team or a site near you to ask about taking part.
Nadia YOUNES, Dr contact
France2 sites
Hospital Versailles
Le Chesnay, 78150
Claire FARINA, MD, cfarina@ght78sud.fr
Nadia YOUNES, MD, nyounes@ght78sud.fr
CH des 4 Villes
Sèvres, 92310
Oleg BYKHOVSKIY, o.bykhovskiy@ch4v.fr
About this study
Official title: Randomized Controlled Trial to Evaluate the Efficacy of Hypnosis and Learning Self-exercises for Outpatients With Moderate to Severe Alcohol Addiction
Many patients are considering the use of so-called "hypnosis" treatments in the field of addictions. However, these techniques lack sufficient levels of evidence with regard to the standards required by Evidence-Based Medicine.
In other domains, however, hypnosis has demonstrated an interesting level of evidence, particularly in pain management.
The investigators will focus on the "Techniques for Activating Consciousness" (TAC), which represent an optimized therapeutic approach derived from hypnotic therapy.
- Conditions
- Alcohol Addiction
- Being tested
- TAC intervention
- Keywords
- Hypnotic therapy, Techniques for Activating Consciousness (TAC), Alcohol addiction
- Medical subject headings
- Alcoholism
What participants receive
What participants receive. In a randomised study each person is assigned to one group by chance.
TAC interventionBehavioural
Patients receiving TAC (Techniques for Activating Consciousness) intervention in addition to standard care
| Study group | Role | What they receive |
|---|---|---|
| Control | No intervention | Not described |
| TAC intervention | Experimental | Not described Receives: Behavioral: TAC intervention |
What is being measured
The primary outcome is the main question the study is designed to answer.
The patient's ability to control alcohol consumption during outpatient follow-up in a CSAPA
The main outcome measure will be the number of weeks to achieve the targeted goal between T0 (first consultation when the objective is set) and M6 (cumulative time).
Measured: 6 months
Secondary outcomes (2)
Controlling addictive behavior in both groups
Evaluation criteria for both groups:
- Cumulative time over 12 months during which the subject meets the target of controlling addictive behavior; percentage of time at target between T0-M6 and T0-M12; number of weeks to reach the target; number of relapses between T0-M6 and T0-M12; time between achieving the target and relapse between T0-M12
- Craving intensity (weekly via electronic patient questionnaire)
- Levels of anxiety and depression (HAD scale) and global relaxation (IERS-3), at T0, M6, and M12
- Care received (interventions, medications) from medical records at M6 and M12
- Patient opinion questionnaire at M6 and M12 on what was perceived as useful or not in their treatment
Measured: 12 months
Evaluation criteria for the TAC group
Weekly self-reports (via electronic patient questionnaire) on the frequency of exercise practice, perceived effectiveness of TAC (Techniques for Activating Consciousness) on their addictive issues (VAS 0-10), and tolerance of TAC (Techniques for Activating Consciousness)
Measured: 12 months
Timeline
From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.
- First posted27 Jan 2026
- Study start15 Apr 2026 (estimated)
- Primary completion15 Jul 2027 (estimated)
- Study completion15 Jan 2028 (estimated)
Resources
- Official record on ClinicalTrials.govThe registry entry this page is built from, with its full change history.
- Other trials for Alcohol AddictionStudies of the same condition, open and under way.
- What the trial phases meanHow a treatment moves from first tests in people to approval.
More details
For doctors and researchers: how the study is designed, who runs it, and its registry IDs.
Study design
- Study type
- Interventional
- Phase
- Phase N/A
- Primary purpose
- Supportive care
- Allocation
- Randomised
- Intervention model
- Parallel groups
- Masking
- None (open label)
- Enrolment
- 98 participants (estimated)
Sponsor and investigators
- Lead sponsor
- Versailles Hospital
- Sponsor type
- University, hospital or other
- Responsible party
- Principal investigator, Dr Claire FARINA, Versailles Hospital
IDs, dates and publications
- ClinicalTrials.gov ID
- NCT07369245
- Sponsor's protocol ID
- P23/03 - TAC-ADDICT
- Acronym
- TAC-ADDICT
- Status last verified
- Nov 2025
- First submitted
- 30 Dec 2025
- Last updated
- 16 Apr 2026
- Results posted
- No
- Data monitoring committee
- No
- FDA-regulated drug
- No
- FDA-regulated device
- No
Study at a glance
From the registry record, last updated by the sponsor on 16 Apr 2026. Recruitment status is as the sponsor reported it: confirm with the study team.
- Official title
- Randomized Controlled Trial to Evaluate the Efficacy of Hypnosis and Learning Self-exercises for Outpatients With Moderate to Severe Alcohol Addiction
- ClinicalTrials.gov ID
- NCT07369245
- Acronym / sponsor ID
- TAC-ADDICT / P23/03 - TAC-ADDICT
- Conditions
- Alcohol Addiction
- Keywords
- Hypnotic therapy, Techniques for Activating Consciousness (TAC), Alcohol addiction
- Study type
- Interventional
- Recruitment status
- Not yet recruiting
- Enrolment
- 98 participants (estimated)
- Lead sponsor
- Versailles HospitalUniversity, hospital or other
- Study start
- 15 Apr 2026 (estimated)
- Primary completion
- 15 Jul 2027 (estimated)
- Study completion
- 15 Jan 2028 (estimated)
- First posted
- 27 Jan 2026 (actual)
- Results
- Not posted in the source record
Clinical summary
The research question as the sponsor registered it. This describes what the study plans to test, not what it found.
Many patients are considering the use of so-called "hypnosis" treatments in the field of addictions. However, these techniques lack sufficient levels of evidence with regard to the standards required by Evidence-Based Medicine.
In other domains, however, hypnosis has demonstrated an interesting level of evidence, particularly in pain management.
The investigators will focus on the "Techniques for Activating Consciousness" (TAC), which represent an optimized therapeutic approach derived from hypnotic therapy.
Study design
- Primary purpose
- Supportive care
- Allocation
- Randomised
- Intervention model
- Parallel groups
- Masking
- None (open label)
- Number of arms
- 2
| Arm | Type | Receives |
|---|---|---|
| Control | No intervention | – |
| TAC intervention | Experimental | Behavioral: TAC intervention |
Who may qualify
- Ages
- 18 years and older
- Sex
- All
- Healthy volunteers
- Not accepted
- Age groups
- Adult, Older adult
Key inclusion criteria (3 listed)
- Adult patients consulting for an alcohol-related addiction problem at the CSAPA of Versailles (sites in Versailles, Trappes, Rambouillet) or at the Centre Hospitalier des 4 Villes (day hospital or CSAPA in Sèvres)
- Patients must meet at least 4 of the 11 DSM-5 criteria (Annex 2), corresponding to moderate to severe addiction
- Patients must be affiliated with the French social security system
Key exclusion criteria (7 listed)
- Refusal to participate
- Decompensated psychiatric pathology contraindicating therapy:
- Severe cognitive impairment, evidenced by inability to perform the clock-drawing test (draw the clock face, place the numbers, and set the hands to 11:10)
- Adults legally protected under French law (deprivation of liberty, legal safeguard, guardianship, curatorship)
- Inability to understand French
Eligibility is decided by the study team after screening; this overview does not establish that a patient qualifies. Full inclusion and exclusion criteria.
Interventions
| Intervention | Type | Arms |
|---|---|---|
| TAC interventionPatients receiving TAC (Techniques for Activating Consciousness) intervention in addition to standard care | Behavioural | TAC intervention |
Primary outcome
The patient's ability to control alcohol consumption during outpatient follow-up in a CSAPA
Time frame: 6 months
The main outcome measure will be the number of weeks to achieve the targeted goal between T0 (first consultation when the objective is set) and M6 (cumulative time).
2 secondary outcomes
Controlling addictive behavior in both groups
Time frame: 12 months
Evaluation criteria for the TAC group
Time frame: 12 months
Results and safety
This study is still under way. Results are not available in the source record yet.
Research links
- Official record on ClinicalTrials.govLast updated by the sponsor 16 Apr 2026.
Related trials for Alcohol Addiction
Recruiting
The Trans-Led Care Study
Substance Abuse, Substance Addiction
Recruiting
Tdcs And cogNitive traininG cOmbined for AUD (TANGO)
Alcohol Use Disorder, Addiction
Not yet recruiting
QAIAx - SGI/SI Smart Health Cities: Microcity Enclave Program (Quantum SI/AGI Agency a/k/a AI City Hall Project - UPSTO App Nos. 64/074,526, 64/063,557, 64/105,164, 63/903,181, 63/729,428, 64/125,360; USPTO EO 9424 Assignment ID: 2101042 / ARN: REEL/FRAME: 76481/0026 - OUSD-R&E, Department of War)
Asperger's Disorder, Asperger Disorder
Recruiting
Safety and Effectiveness of the BrainsWay Deep Transcranial Magnetic Stimulation (Deep TMS) for Treatment and Reduction of Heavy Drinking in Individuals With of Alcohol Use Disorder (AUD)
Alcohol Use Disorder, Alcoholism
Active, not recruiting
Evaluation of Effectiveness of the LifeSkills Training - Lombardia - Primary Shool Program ( Val3P-LST )
Well Being, Drug Addiction
Referral and contact
AzTrials does not enrol participants or take referrals. Contact the study team or a site listed below; they decide who can take part.
Nadia YOUNES, Dr contact
2 sites in 1 country: see every site and its status.
Questions about this trial
What is this clinical trial studying?
A study testing TAC intervention in people with Alcohol Addiction, run by Versailles Hospital at 2 sites in France.
The full registered description is in the About this study section and the official record.
Who may be eligible to take part?
The sponsor lists 3 inclusion and 7 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.
Is this clinical trial currently recruiting?
The record says: opening soon, as of the sponsor's last update on 16 Apr 2026. Status can change between updates, so confirm with the study contact before making plans.
Where is the study taking place?
The record lists 2 sites in France. Whether a site is taking part right now should be confirmed with that site. See every site.
What are the possible benefits and risks?
They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.
Are results available for this study?
This study is still under way. Results are not available in the source record yet.
How can a doctor refer a patient or contact the research team?
Contact Claire FARINA, Dr (01 39 63 93 80 ext. +33, cfarina@ght78sud.fr), or a site near the patient. AzTrials does not enrol participants or take referrals.
What does the primary outcome measure?
The patient's ability to control alcohol consumption during outpatient follow-up in a CSAPA (time frame: 6 months). It is what the study was designed to measure, not a finding.
Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?
No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.
How often is this information updated?
AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 16 Apr 2026; AzTrials last refreshed its copy on 6 Nov 2026.